CGM outperformed HbA1c in predicting glycemic progression in youth with prediabetes, indicating its potential for risk assessment.
CGM metrics outperformed HbA1c in predicting short-term glycemic progression in youth with prediabetes, supporting CGM as a promising adjunctive tool for early risk stratification.
No takes yet. Share an insight, caveat, or question.
Segev et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: